ClearPoint Neuro Dirección
Dirección controles de criterios 3/4
El CEO de ClearPoint Neuro's es Joe Burnett , nombrado en Nov 2017, tiene una permanencia de 6.42 años. compensación anual total es $2.00M, compuesta por 25.9% salario y 74.1% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.97% de las acciones de la empresa, por valor de $1.45M. La antigüedad media del equipo directivo y de la junta directiva es de 3.1 años y 5.5 años, respectivamente.
Información clave
Joe Burnett
Chief Executive Officer (CEO)
US$2.0m
Compensación total
| Porcentaje del salario del CEO | 25.9% |
| Permanencia del CEO | 6.5yrs |
| Participación del CEO | 1.0% |
| Permanencia media de la dirección | 3.2yrs |
| Promedio de permanencia en la Junta Directiva | 5.6yrs |
Actualizaciones recientes de la dirección
Recent updates
ClearPoint Neuro: Macro-Induced Multiple Compression
Apr 25Are ClearPoint Neuro, Inc. (NASDAQ:CLPT) Investors Paying Above The Intrinsic Value?
Apr 19
Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report
Mar 15Should You Investigate ClearPoint Neuro, Inc. (NASDAQ:CLPT) At US$6.18?
Jan 04Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Dec 06Is There An Opportunity With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 41% Undervaluation?
Nov 06Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Aug 18ClearPoint Neuro, Inc. (NASDAQ:CLPT) Looks Just Right With A 40% Price Jump
Apr 17Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Jan 03ClearPoint Neuro: Continuous Great Execution
Sep 19ClearPoint Neuro: Picks & Shovels Galore
Aug 19ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?
Aug 18ClearPoint Neuro: A 'Picks And Shovels' Biotech Company
Jul 25ClearPoint Neuro: Continuous Execution Despite Covid Headwind
May 20Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Apr 25ClearPoint Neuro: A Strong Recovery Play Once COVID Subsides
Mar 18ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?
Jan 19ClearPoint Neuro: Underlying Growth Potential Concealed By COVID
Jan 14ClearPoint Neuro: Becoming The Neurosurgical Platform Of Choice
Oct 01ClearPoint Neuro: Path To Being The Neurological Navigation Platform Company
Aug 06Health Check: How Prudently Does ClearPoint Neuro (NASDAQ:CLPT) Use Debt?
Jul 19Clearpoint Neuro (CLPT) Investor Presentation - Slideshow
May 28Why We Think Shareholders May Be Considering Bumping Up ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) CEO Compensation
May 27US$35.00 - That's What Analysts Think ClearPoint Neuro, Inc. (NASDAQ:CLPT) Is Worth After These Results
May 13ClearPoint Neuro partners with D&K Engineering
May 10ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Path To Profitability
Apr 16Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$518k | -US$22m |
| Sep 30 2023 | n/a | n/a | -US$22m |
| Jun 30 2023 | n/a | n/a | -US$21m |
| Mar 31 2023 | n/a | n/a | -US$18m |
| Dec 31 2022 | US$2m | US$494k | -US$16m |
| Sep 30 2022 | n/a | n/a | -US$16m |
| Jun 30 2022 | n/a | n/a | -US$16m |
| Mar 31 2022 | n/a | n/a | -US$16m |
| Dec 31 2021 | US$1m | US$445k | -US$14m |
| Sep 30 2021 | n/a | n/a | -US$12m |
| Jun 30 2021 | n/a | n/a | -US$9m |
| Mar 31 2021 | n/a | n/a | -US$7m |
| Dec 31 2020 | US$784k | US$435k | -US$7m |
| Sep 30 2020 | n/a | n/a | -US$7m |
| Jun 30 2020 | n/a | n/a | -US$6m |
| Mar 31 2020 | n/a | n/a | -US$6m |
| Dec 31 2019 | US$864k | US$366k | -US$6m |
| Sep 30 2019 | n/a | n/a | -US$5m |
| Jun 30 2019 | n/a | n/a | -US$5m |
| Mar 31 2019 | n/a | n/a | -US$6m |
| Dec 31 2018 | US$515k | US$360k | -US$6m |
| Sep 30 2018 | n/a | n/a | -US$7m |
| Jun 30 2018 | n/a | n/a | -US$7m |
| Mar 31 2018 | n/a | n/a | -US$7m |
| Dec 31 2017 | US$930k | US$55k | -US$7m |
Compensación vs. Mercado: La compensación total de Joe($USD2.00M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD668.06K).
Compensación vs. Ingresos: La compensación de Joe ha sido consistente con los resultados de la empresa en el último año.
CEO
Joe Burnett (46 yo)
6.5yrs
Permanencia
US$1,995,337
Compensación
Mr. Joseph Michael Burnett, also known as Joe, has been Chief Executive Officer, President and Director of ClearPoint Neuro, Inc. since November 7, 2017. Mr. Burnett has spent his entire career in medical...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 6.5yrs | US$2.00m | 0.97% $ 1.4m | |
| Chief Financial Officer | 3.3yrs | US$930.98k | 0.20% $ 291.0k | |
| Chief Business Officer | 1.3yrs | US$838.49k | sin datos | |
| Chief Operating Officer | 1.6yrs | sin datos | 0.16% $ 238.3k | |
| General Counsel & Secretary | 3.1yrs | sin datos | sin datos | |
| Vice President of Marketing | 4.5yrs | sin datos | sin datos |
3.2yrs
Permanencia media
40.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de CLPT se considera experimentado (3.1 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 6.5yrs | US$2.00m | 0.97% $ 1.4m | |
| Independent Chairman of the Board | 7yrs | US$227.62k | 0.28% $ 406.1k | |
| Independent Director | 4.7yrs | US$189.99k | 0.076% $ 111.1k | |
| Independent Director | 2.8yrs | US$202.49k | 0.047% $ 69.8k | |
| Independent Director | 9.7yrs | US$192.65k | 0.20% $ 298.9k | |
| Independent Director | 2.5yrs | US$182.49k | 0.049% $ 71.3k | |
| Independent Director | 10.2yrs | US$194.75k | 0.16% $ 241.1k | |
| Director | 4.1yrs | US$174.99k | 0.045% $ 66.6k |
5.6yrs
Permanencia media
63yo
Promedio de edad
Junta con experiencia: La junta directiva de CLPT se considera experimentada (4.6 años de antigüedad promedio).